Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1997-07-18
2000-01-25
Degen, Nancy
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
4353201, A61K 3170, C12N 1585
Patent
active
060178973
ABSTRACT:
Non-replicating vectors containing a nucleotide sequence coding for an F protein of respiratory syncytial virus (RSV) and a promoter for such sequence, preferably a cytomegalovirus promoter, are described for in vivo immunization. Such non-replicating vectors, including plasmids, also may contain a further nucleotide sequence located adjacent to the RSV F protein encoding sequence to enhance the immunoprotective ability of the RSV F protein when expressed in vivo. Such non-replicating vectors may be used to immunize a host against disease caused by infection with RSV, including a human host, by administration thereto, and may be formulated as immunogenic compositions with pharmaceutically-acceptable carriers for such purpose. Such vectors also may be used to produce antibodies for detection of RSV infection in a sample.
REFERENCES:
patent: 5149650 (1992-09-01), Wertz et al.
patent: 5589466 (1996-12-01), Felgner et al.
McIntosh, K. Et al In: Fields BN, Knipe, DM, editors. Virology, New York: Raven Press 1990: 1045-1072.
Wertz, G.W. et al, Biotechnology 1992, 20: 151-176.
Johnson et al., J. Virol. 1987, 61: 3163-3165.
Crowe, J.E., Vaccine 1995, 13: 415-421.
Ulmer, Current Opinion, Invest Drugs, 1993, 2: 983-989.
Tang et al., Nature 1992, 356: 152-154.
Furth et al. Analytical Biochemistry, 1992, 205: 365-368.
Chapman, B.S. et al, Nucl. Acids Res. 1991, 19: 3979-3986.
Graham, B.S. et al., J. Mod. Virol. 1988 26: 153-162.
Nabel, G.J. et al Proc. Natl. Acad. Sci. USA 90:11307-11311, 1993.
Du, R.P. et al 1994, Biotechnology 12: 813-818.
Prince, G.A. et al, 1978. Ame J. Pathol. 93: 771-790.
Davis et al, Vaccine 1994, 12: 1503-1509.
Chanock, Robert M. et al, Pediatrics vol. 90 No. 1, Jul. 1992, pp. 137-142.
Groothuis et al, N. Engl. J. Med. 329:1524-1530, 1993.
Walsh et al, J. Infec. Dis., 155: 1198-1204, 1987.
Lounsbach et al, Journal of General Virology 74, 2559-2565 (1993).
Wathen et al, J. Infect. Dis. 159: 255-264 (1989).
Wertz et al, J. Virol 61: 293-301 (1987).
Tang et al (1993) J. Biol. Chem. 268:9522-9525.
Collis et al (1990) Embo J. 9:233-240.
Ewasyshyn Mary E.
Klein Michel H.
Li Xiaomao
Sambhara Suryaprakash
Degen Nancy
Pasteur Merieux Connaught Canada
Schwartzman Robert
LandOfFree
Nucleic acid respiratory syncytial virus vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acid respiratory syncytial virus vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid respiratory syncytial virus vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2316023